Albicu Tablet
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
MFDS item code 201600260 · Approved 2016.01.14
This product's status changed to Expired on 2026.01.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of acid-related disorders (e.g., ulcers and gastritis); prevention of Mendelson's syndrome
This medicine is effective primarily for gastrointestinal diseases such as gastric ulcers, gastritis, and duodenal ulcers. It is also used for the treatment of Zollinger-Ellison syndrome and gastroesophageal reflux disease. It helps prevent ulcers that may occur after surgery and helps prevent Mendelson syndrome before anesthesia. This medicine is also used to treat gastric and duodenal ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs). It is used to alleviate symptoms and aid in the healing of various gastrointestinal-related diseases.
Usually, take 2 tablets per dose twice daily, in the morning and at bedtime, with or without food. 1) Gastric and duodenal ulcers: Administer 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose twice daily, in the morning and at bedtime. The dose is the same for ulcers caused by nonsteroidal anti-inflammatory drugs and for combination therapy to prevent gastric and duodenal ulcers during long-term administration of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis: Administer 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily at bedtime. However, the dose may be increased to 4 tablets per dose 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome: Initiate treatment with an initial dose of 2 tablets per dose 3 times daily and increase the dose as needed. In severe cases, up to 6g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to acute stress ulcers associated with peptic ulcers and acute gastric mucosal lesions: Once oral administration is possible, switch from injection to oral administration and administer 2 tablets per dose twice daily. 5) Administer 2 tablets 2 hours before induction of anesthesia. In this case, it is preferable to also administer 2 tablets on the night before surgery. For patients with severe renal impairment and creatinine clearance of 50ml/min or less, take 2 tablets per dose once daily at bedtime. This may vary depending on the patient's condition. Since hemodialysis reduces the blood concentration of the drug, readjust the dosing schedule immediately after hemodialysis.
Children aged 8-18 years may take 2 tablets per dose (2mg/kg as ranitidine) up to twice daily.
This medicine should not be used by patients receiving dialysis treatment. Those who have had an allergic reaction to ranitidine hydrochloride should not take this medicine. Patients with impaired kidney function should use it cautiously, as the drug concentration may increase, requiring a reduction in dosage or an increase in dosing interval. Patients with impaired liver function should also pay attention when taking this medicine. Patients with a history of allergy to the medicine or the elderly should also use it cautiously. During treatment with this medicine, severe allergic reactions or shock may occur infrequently; thus, attention should be paid to symptoms. If allergic symptoms such as skin rash, hives, swelling of the face or neck, fever, shortness of breath, or low blood pressure occur, the medication should be discontinued immediately. There may be a decrease in blood cell count, or liver function tests may show a temporary increase, and in rare cases, serious blood disorders have been reported. Symptoms of liver dysfunction may also occur, and regular testing may be required. Symptoms of arrhythmia or alterations in heart rate may arise; attention should be paid to any abnormalities. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, abdominal distension, and abdominal pain, and stool color may change, but this does not require special treatment. In rare cases, neurological symptoms such as dizziness, drowsiness, confusion, seizures, insomnia, headaches, and a feeling of heaviness may occur, so caution is advised. Gynecomastia or sexual dysfunction has been reported, but a direct correlation with this medication is not clear. Joint pain, skin rash, hair loss, itching, and discoloration of the tongue may occur, but these symptoms are mostly temporary. This medicine should not be used long-term, and patients with kidney disease must consult their physician or pharmacist before use. The treatment process should be closely monitored, using the minimum effective dose, and if there is no effect, switching to another medication is recommended. Women who are pregnant or may become pregnant should use this medication only when the benefits outweigh the risks, as its safety has not been established. This medication can also be transferred through breast milk; therefore, breastfeeding should be avoided while taking it. The safety in children has not been fully studied; therefore, it should be used cautiously in children. Some urine tests may yield false results, so care should be taken regarding the testing methods. In the case of overdose, emergency treatment such as vomiting or gastric lavage may be necessary, and if needed, blood dialysis may be used to remove the drug. This medication can mask symptoms of gastric cancer, so it should only be used after confirming that it is not a malignant condition, and eye health checks are recommended for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly sealed container to prevent air exposure and kept at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the drug's effectiveness for a longer period.
Green round film-coated tablet
30 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.